BMJ  2004;328:1271-1272 (29 May), doi:10.1136/bmj.328.7451.1271

Editorial

The free trade agreement between Australia and the United States

Undermines Australian public health and protects US interests in pharmaceuticals

The first 150 words of the full text of this article appear below.

On 4 March 2004 Australia and the United States released the text of a bilateral trade agreement designed to reduce trade barriers between the countries.¹ Surprisingly, the Australian pharmaceutical benefits scheme (the national drug subsidy programme operated by the federal government of Australia) was part of the deal, with Australian negotiators conceding to several US demands. These included the creation of an independent review body to examine drugs rejected by the Pharmaceutical Benefits Advisory Committee. Under existing legislation only the advisory committee can recommend listing of drugs for subsidy. However, the dissenting views of another review body, supported by publicity and lobbying, may undermine the famously tough stance of this committee concerning the cost effectiveness and prices of pharmaceutical products. In addition, Australia has agreed to changes in intellectual property protection that, among other things, increase the risk of delayed entry of generic drugs on to the Australian market. The . . . [Full text of this article]

Research School of Social Sciences, Australian National University, ACT 0200, Australia

School of Medical Practice and Population Health, University of Newcastle, NSW 2308, Australia (mddah@mail.newcastle.edu.au)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Cataclysm and departure

Richard Smith
BMJ 2004 328: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Moynihan, R. (2005). New free trade agreement sparks fight over drug pricing. BMJ 330: 213-213 [Full text]  
• Reidenberg, M. M, Walley, T. (2004). The pros and cons of essential medicines for rich countries. BMJ 329: 1172-1172 [Full text]  

Rapid Responses:

Read all Rapid Responses

The PBS should be adopted by the UK

Fred Johnson
bmj.com, 27 May 2004 [Full text]

Oppose the weakening of the PBS by the US-Australia FTA

Ken J Harvey
bmj.com, 29 May 2004 [Full text]

US FTA Medicines Strategies

Thomas Faunce
bmj.com, 30 May 2004 [Full text]

Testimony to the US House Ways & Means Committee on the Australian-US FTA

Kevin Outterson
bmj.com, 23 Jun 2004 [Full text]

Unwarranted fears about Australian FTA

Eric Noehrenberg
bmj.com, 23 Jun 2004 [Full text]

Read my lips - there will be NO increase !

Dr. Herbert H. Nehrlich
bmj.com, 23 Jun 2004 [Full text]